AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $590.87m
- $608.89m
- $44.55m
Brief: Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual Film
Brief: Aquestive Therapeutics, Inc. Q3 revenue USD 13.002 million
Aquestive Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Completes $45 Mln Debt Refinancing
Aquestive Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Anticipates Increasing 2023 Revenue
Brief: Aquestive Therapeutics Inc Files For Resale Of Up To 2.75 Million Shares Of Common Stock By The Selling Stockholder
Brief: Aquestive Therapeutics Receives FDA Acceptance Of New Drug Application (NDA) For Libervant
Aquestive Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Reports Positive Results From Latest Clinical Studies Evaluating Pharmacokinetic And Pharmacodynamic Performance Of Anaphylm ™ (Epinephrine) Sublingual Film And Provides Findings From Recent Auto-Injector Clinical Study
Aquestive Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Aquestive Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
Aquestive Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Receives Conditional FDA Acceptance Of Proprietary Name Anaphylm™ For Lead Candidate Aqst-109 (Epinephrine Sublingual Film)
Brief: Aquestive Therapeutics Inc Says Received Notice From Nasdaq Informing Co That It Has Regained Compliance With Nasdaq
Brief: Aquestive Therapeutics Expands License And Supply Agreement With Pharmanovia For Libervant™ (Diazepam) Buccal Film To Additional Global Markets
Brief: Aquestive Therapeutics Holds No Any Deposits Or Securities At Silicon Valley Bank
U.S. RESEARCH ROUNDUP- Ameresco, Bioxcel Therapeutics, Roblox